YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate Cancer

Clinical trial NCT07583160 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07583160
Sponsor: Changhai Hospital
Status: ENROLLING_BY_INVITATION
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Castration-Resistant Prostate Cancer Patients Castration-Resistant Prostate Cancer (CRPC)Prostate Neoplasms

Start date: 2026-06-01
Primary completion: 2028-06-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.